Financial results - Z GROUP PHARMA SRL

Financial Summary - Z Group Pharma Srl
Unique identification code: 13669440
Registration number: J39/17/2001
Nace: 8299
Sales - Ron
-
Net Profit - Ron
-61
Employee
The most important financial indicators for the company Z Group Pharma Srl - Unique Identification Number 13669440: sales in 2023 was - euro, registering a net profit of -61 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Alte activitati de servicii suport pentru intreprinderi n.c.a. having the NACE code 8299.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Z Group Pharma Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 824 2.373 2.892 1.877 0 0 0 0 0 0
Total Income - EUR 38.062 11.407 54.781 2.485 416 22.066 0 41.856 0 0
Total Expenses - EUR 8.526 6.193 4.566 4.849 3.812 3.257 31.693 2.067 1.485 61
Gross Profit/Loss - EUR 29.536 5.214 50.215 -2.364 -3.397 18.809 -31.693 39.790 -1.485 -61
Net Profit/Loss - EUR 29.498 5.137 50.128 -2.438 -3.397 18.809 -31.693 39.776 -1.485 -61
Employees 1 1 0 1 0 1 0 1 1 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Z Group Pharma Srl

Rating financiar

Financial Rating -
Z Group Pharma Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Z Group Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Z Group Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Z Group Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Z Group Pharma Srl - CUI 13669440

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 0 0 0 0 0 0 0
Current Assets 416.124 428.104 478.696 473.375 438.774 459.298 421.943 454.431 455.841 454.398
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 5.047 1.800 3.479 3.764 727 891 892 1.014 1.017 1.025
Cash 411.078 426.304 475.217 469.611 438.047 458.407 421.050 453.418 454.824 453.373
Shareholders Funds 344.457 351.648 398.189 389.013 353.101 371.939 334.682 367.036 366.690 365.517
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 72.482 76.456 80.507 84.362 85.674 87.358 87.261 87.395 89.151 88.881
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8299 - 8299"
CAEN Financial Year 8299
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 454.398 euro in 2023 which includes Inventories of 0 euro, Receivables of 1.025 euro and cash availability of 453.373 euro.
The company's Equity was valued at 365.517 euro, while total Liabilities amounted to 88.881 euro. Equity decreased by -61 euro, from 366.690 euro in 2022, to 365.517 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Z Group Pharma Srl

Comments - Z Group Pharma Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.